MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Clinical trial NCT05986981 · UNKNOWN

Trial details

NCT number: NCT05986981
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2023-08-01
Primary completion: 2023-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.